This working paper assesses evidence on and arguments made about supervised consumption sites (RAND)
Archives for 2020
Bibliography: All Publications
Family Drug and Alcohol Courts under Covid-19: A Practice Briefing
This briefing examines how the nine existing FDACs across England are adapting to service delivery during the current crisis. It highlights the practical challenges facing practitioners, judges and families, and shines a light on specific solutions that have been developed in response to the Covid-19 pandemic (Centre for Justice Innovation)
COVID-19 is changing the route of illicit drug flows, says UNODC report
UNODC has collected data from government authorities, UNODC field offices, open sources, and information from media that are now summarized in the COVID-19 and DrugMarkets report
Summary of monitoring of cryptomarkets for drug listings, 1 February 2014 – 31 January 2020
This summary reports on trends in the availability and type of substances sold on the internet via cryptomarkets from 1 February 2014 to 31 January 2020 (NDARC)
EMCDDA special report: COVID-19 and drugs – Drug supply via darknet markets
This report is a rapid and preliminary analysis of the impact of COVID-19 on selected online markets (EMCDDA)
Clinical guidelines for use of depot buprenorphine (Buvidal® ) in the treatment of opioid dependence (PDF)
This Clinical Guideline has been developed to inform decision-making by clinicians prescribing and/or patients being treated with Buvidal® long-acting injected buprenorphine preparations (SMMGP)
Safety of low dose cannabidiol
The review identified that there were potential conditions for low dose cannabidiol that would not require oversight by a medical practitioner. (Australian Government)
Novel benzodiazepines: prevalence and harms in the UK
This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government (ACMD)
Trends in the availability and type of drugs sold on the internet via cryptomarkets
January 2019 – January 2020 (NDARC)
Seoul Searching
South Korea’s AI Counter-Cryptomarket Capability and Associated Privacy Dilemmas (gdpo)
Gender and Irish Drug Policy
Report submitted to the working group as part of the ‘Implementing a gender approach in different drug policy areas: from prevention, care and treatment service to law enforcement’ project (UCD)
Adulterants, Contaminants and Co-occurring Substances in Drugs on the Illegal Market in Canada
This bulletin provides a snapshot of the contents of drugs on the illegal, unregulated market in Canada, with the view to raising awareness among stakeholders, including people who use drugs, service providers, and policy makers, that drug contamination is extensive and pervasive, and contributes significantly to drugrelated harms (CCSA)
Cannabis and Capitalism: The Question of Ownership Within Drug Policy Reform
The idea of certain drugs as bad, dangerous and requiring prohibition by law it is a relatively recent social phenomenon, with the first international laws prohibiting drugs only appearing at the start of the twentieth century. Since then, the so-called War on Drugs has become a huge driver for the worlds ever-growing prison population, with more than 1 in 8 of all prisoners currently incarcerated in British prisons serving their sentences for drug offences (Common Wealth)
Nonfatal Drug Overdoses Treated in Emergency Departments — United States, 2016–2017
From 2016 to 2017, the nonfatal overdose ED visits rates for all drugs, all opioids, nonheroin opioids, heroin, and cocaine increased significantly, whereas those for benzodiazepines decreased significantly (CDC)
A review of legislative initiatives on the liability of drug-related advocacy (propaganda) in Russia, Ukraine, and Kazakhstan during the second half of 2019 and early 2020
possible risks for social programmes aimed at working with people who use drugs (ehra)
Standard Operating Procedure for using evidence in ACMD reports
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice
EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers
What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the frontline? (EMCDDA)
Out of harm’s way (PDF)
This document has been written in response to one of eight recommendations in the West Midlands PCC’s Drugs Policy Report (2018), a report that adopts a new approach that is dictated by evidence and compassion and where the emphasis centres on harm reduction to help to lower crime, save money and support communities (West Midlands Police and Crime Commissioner)
Wastewater analysis and drugs — a European multi-city study (Perspectives on drugs)
The results provide a valuable snapshot of the drug flow through the cities involved, revealing marked geographical variations (EMCDDA)
National Wastewater Drug Monitoring Program—Ninth report
The Australian Criminal Intelligence Commission (ACIC) has commissioned The University of Queensland, and through it the University of South Australia, to undertake the data collection and analysis that underpins the report
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- Next Page »